RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      SCIE KCI등재

      Survey of the management of patients with bronchiectasis: a pilot investigation in Asian populations = Survey of the management of patients with bronchiectasis: a pilot investigation in Asian populations

      한글로보기

      https://www.riss.kr/link?id=A107897206

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Background/Aims: Although international guidelines for bronchiectasis management have been published in Western countries, there is a lack of data about their application in Asian populations including patients with different phenotypes. We aimed to i...

      Background/Aims: Although international guidelines for bronchiectasis management have been published in Western countries, there is a lack of data about their application in Asian populations including patients with different phenotypes. We aimed to investigate the current status of bronchiectasis management in Asian populations.
      Methods: A nationwide questionnaire survey was performed of Asian respiratory specialists from South Korea, Japan, Taiwan, Singapore, Vietnam, and Sri Lanka. Participants were invited by e-mail to answer a questionnaire comprising 25 questions based on international guidelines for the management of bronchiectasis.
      Results: A total of 221 physicians participated in the survey. About half of them were Korean (50.2%), with the next most common nationalities being Japanese (23.1%), Taiwanese (13.6%), and Singaporean (7.7%). Only 18 (8.1%) responders had local guidelines for bronchiectasis. While 85 (38.5%) responders checked sputum acid-fast bacillus smear/culture about 1 to 3 times per year, only a small proportion of responders routinely performed a serum immunoglobulin test (36/221, 16.3%) or evaluated for allergic bronchopulmonary aspergillosis (41/221, 18.6%). Less than half (43.4%) of responders performed eradication treatment in patients with drug-sensitive Pseudomonas aeruginosa infection, mainly due to the limited availability of inhaled antibiotics (34.8%). In addition, 58.6% of responders considered physiotherapy such as airway clearance and pulmonary rehabilitation.
      Conclusions: Discrepancies might exist between guideline recommendations and practice for bronchiectasis management in Asian populations, partly due to the limited availability of treatment in each country. The development of local guide-lines that consider the phenotypes and situation will help to standardize and improve the management of bronchiectasis.

      더보기

      참고문헌 (Reference)

      1 Lee AL, "The short and long term effects of exercise training in non-cystic fibrosis bronchiectasis : a randomised controlled trial" 15 : 44-, 2014

      2 Goeminne PC, "The economic burden of bronchiectasis: known and unknown. A systematic review" 19 : 54-, 2019

      3 Odnoletkova I, "The burden of common variable immunodeficiency disorders : a retrospective analysis of the European Society for Immunodeficiency(ESID)registry data" 13 : 201-, 2018

      4 Al-Jahdali H, "The Saudi Thoracic Society guidelines for diagnosis and management of noncystic fibrosis bronchiectasis" 12 : 135-161, 2017

      5 Martinez-Garcia MA, "Spanish guidelines on treatment of bronchiectasis in adults" 54 : 88-98, 2018

      6 Martinez-Garcia MA, "Spanish guidelines on the evaluation and diagnosis of bronchiectasis in adults" 54 : 79-87, 2018

      7 Hill AT, "Pulmonary exacerbation in adults with bronchiectasis : a consensus definition for clinical research" 49 : 1700051-, 2017

      8 임정우, "Prevalence of Primary Immunodeficiency in Korea" 대한의학회 27 (27): 788-793, 2012

      9 Choi H, "Population-based prevalence of bronchiectasis and associated comorbidities in South Korea" 54 : 1900194-, 2019

      10 White L, "Outcomes of Pseudomonas eradication therapy in patients with non-cystic fibrosis bronchiectasis" 106 : 356-360, 2012

      1 Lee AL, "The short and long term effects of exercise training in non-cystic fibrosis bronchiectasis : a randomised controlled trial" 15 : 44-, 2014

      2 Goeminne PC, "The economic burden of bronchiectasis: known and unknown. A systematic review" 19 : 54-, 2019

      3 Odnoletkova I, "The burden of common variable immunodeficiency disorders : a retrospective analysis of the European Society for Immunodeficiency(ESID)registry data" 13 : 201-, 2018

      4 Al-Jahdali H, "The Saudi Thoracic Society guidelines for diagnosis and management of noncystic fibrosis bronchiectasis" 12 : 135-161, 2017

      5 Martinez-Garcia MA, "Spanish guidelines on treatment of bronchiectasis in adults" 54 : 88-98, 2018

      6 Martinez-Garcia MA, "Spanish guidelines on the evaluation and diagnosis of bronchiectasis in adults" 54 : 79-87, 2018

      7 Hill AT, "Pulmonary exacerbation in adults with bronchiectasis : a consensus definition for clinical research" 49 : 1700051-, 2017

      8 임정우, "Prevalence of Primary Immunodeficiency in Korea" 대한의학회 27 (27): 788-793, 2012

      9 Choi H, "Population-based prevalence of bronchiectasis and associated comorbidities in South Korea" 54 : 1900194-, 2019

      10 White L, "Outcomes of Pseudomonas eradication therapy in patients with non-cystic fibrosis bronchiectasis" 106 : 356-360, 2012

      11 Chalmers JD, "New insights into the epidemiology of bronchiectasis" 154 : 1272-1273, 2018

      12 Visser SK, "Management of Australian adults with bronchiectasis in tertiary care: evidence-based or access-driven?" 197 : 803-810, 2019

      13 Ringshausen FC, "Increasing bronchiectasis prevalence in Germany, 2009-2017 : a population-based cohort study" 54 : 1900499-, 2019

      14 Denning DW, "Global burden of allergic bronchopulmonary aspergillosis with asthma and its complication chronic pulmonary aspergillosis in adults" 51 : 361-370, 2013

      15 Park J, "Factors associated with radiologic progression of non-cystic fibrosis bronchiectasis during long-term follow-up" 21 : 1049-1054, 2016

      16 Polverino E, "European Respiratory Society guidelines for the management of adult bronchiectasis" 50 : 1700629-, 2017

      17 Huang HY, "Etiology and characteristics of patients with bronchiectasis in Taiwan : a cohort study from 2002 to 2016" 20 : 45-, 2020

      18 Orriols R, "Eradication therapy against Pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis" 90 : 299-305, 2015

      19 Lee H, "Epidemiology of nontuberculous mycobacterial infection, South Korea, 2007-2016" 25 : 569-572, 2019

      20 Prevots DR, "Epidemiology of human pulmonary infection with nontuberculous mycobacteria : a review" 36 : 13-34, 2015

      21 Zanini A, "Effects of pulmonary rehabilitation in patients with non-cystic fibrosis bronchiectasis : a retrospective analysis of clinical and functional predictors of efficacy" 89 : 525-533, 2015

      22 de la Rosa Carrillo D, "Cost of hospitalizations due to exacerbation in patients with non-cystic fibrosis bronchiectasis" 96 : 406-416, 2018

      23 King PT, "Characterisation of the onset and presenting clinical features of adult bronchiectasis" 100 : 2183-2189, 2006

      24 Dhar R, "Bronchiectasis in India : results from the European Multicentre Bronchiectasis Audit and Research Collaboration(EMBARC)and Respiratory Research Network of India Registry" 7 : e1269-e1279, 2019

      25 Chalmers JD, "Bronchiectasis : new therapies and new perspectives" 6 : 715-726, 2018

      26 Barker AF, "Bronchiectasis" 346 : 1383-1393, 2002

      27 Hill AT, "British Thoracic Society guideline for bronchiectasis in adults" 74 (74): 1-69, 2019

      28 Pasteur MC, "An investigation into causative factors in patients with bronchiectasis" 162 (162): 1277-1284, 2000

      29 Kadowaki T, "An analysis of etiology, causal pathogens, imaging patterns, and treatment of Japanese patients with bronchiectasis" 53 : 37-44, 2015

      30 Gao YH, "Aetiology of bronchiectasis in adults : a systematic literature review" 21 : 1376-1383, 2016

      31 Guan WJ, "Aetiology of bronchiectasis in Guangzhou, southern China" 20 : 739-748, 2015

      32 Shoemark A, "Aetiology in adult patients with bronchiectasis" 101 : 1163-1170, 2007

      33 Aksamit TR, "Adult patients with bronchiectasis : a first look at the US Bronchiectasis Research Registry" 151 : 982-992, 2017

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2011-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2008-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2007-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2005-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 1.37 0.26 1.02
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.83 0.73 0.566 0.13
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼